Grape seed extract and resveratrol prevent 4‐nitroquinoline 1‐oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses
暂无分享,去创建一个
R. Agarwal | R. Sclafani | D. Orlicky | G. Deep | C. Agarwal | J. Wisell | Sangeeta Shrotriya | Alpna Tyagi | Xiao-Jing Wang
[1] D. Ribeiro,et al. Polyphenols as a chemopreventive agent in oral carcinogenesis: putative mechanisms of action using in-vitro and in-vivo test systems , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[2] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[3] M. Tsai,et al. Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis. , 2012, Food & function.
[4] E. Selimoğlu,et al. The effect of resveratrol on the prevention of cisplatin ototoxicity , 2012, European Archives of Oto-Rhino-Laryngology.
[5] M. Chou,et al. Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. , 2012, Molecular nutrition & food research.
[6] H. Rikiishi. Autophagic action of new targeting agents in head and neck oncology , 2012, Cancer biology & therapy.
[7] R. Agarwal,et al. Generation of reactive oxygen species by grape seed extract causes irreparable DNA damage leading to G2/M arrest and apoptosis selectively in head and neck squamous cell carcinoma cells. , 2012, Carcinogenesis.
[8] J. S. Gutkind,et al. Metformin Prevents the Development of Oral Squamous Cell Carcinomas from Carcinogen-Induced Premalignant Lesions , 2012, Cancer Prevention Research.
[9] J. L. Lacau St Guily,et al. HPV and head and neck cancer. , 2012, European annals of otorhinolaryngology, head and neck diseases.
[10] E. Rosenthal,et al. Grape Seed Proanthocyanidins Inhibit the Invasiveness of Human HNSCC Cells by Targeting EGFR and Reversing the Epithelial-To-Mesenchymal Transition , 2012, PloS one.
[11] D. Parkin,et al. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.
[12] R. Peto,et al. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 , 2011, British Journal of Cancer.
[13] R. Mehrotra,et al. Exciting new advances in oral cancer diagnosis: avenues to early detection , 2011, Head & neck oncology.
[14] R. Agarwal,et al. Resveratrol Selectively Induces DNA Damage, Independent of Smad4 Expression, in Its Efficacy against Human Head and Neck Squamous Cell Carcinoma , 2011, Clinical Cancer Research.
[15] C. Van Waes,et al. EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy , 2011, Expert opinion on therapeutic targets.
[16] K. Coombes,et al. Proteomic Profiling Identifies Pathways Dysregulated in Non-small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways with Recurrence , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[17] S. Advani,et al. Targeting mTOR pathway: A new concept in cancer therapy , 2010, Indian Journal of Medical and Paediatric Oncology.
[18] M. Loda,et al. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer , 2010, British Journal of Cancer.
[19] Neeraj Singhal,et al. Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects , 2010, Clinical pharmacokinetics.
[20] D. Grandér,et al. Autophagy: cancer therapy's friend or foe? , 2010, Future medicinal chemistry.
[21] A. García-García,et al. Genetic and molecular alterations associated with oral squamous cell cancer (Review). , 2009, Oncology reports.
[22] Martin Görner,et al. HPV & head and neck cancer: a descriptive update , 2009, Head & neck oncology.
[23] R. Agarwal,et al. Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. , 2009, The Journal of nutrition.
[24] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[25] A. Saad,et al. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[26] R. Hasina,et al. ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis , 2009, Cancer Prevention Research.
[27] V. Patel,et al. Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model , 2009, Cancer Prevention Research.
[28] K. Wong. Oral-Specific Chemical Carcinogenesis in Mice: An Exciting Model for Cancer Prevention and Therapy , 2009, Cancer Prevention Research.
[29] D. Carling,et al. The regulation of AMP-activated protein kinase by upstream kinases , 2008, International Journal of Obesity.
[30] J. Milner,et al. Diet, Autophagy, and Cancer: A Review , 2008, Cancer Epidemiology Biomarkers & Prevention.
[31] R. Agarwal,et al. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine–induced urinary bladder carcinogenesis in male ICR mice , 2007, Molecular Cancer Therapeutics.
[32] H. A. Weber,et al. Comparison of proanthocyanidins in commercial antioxidants: grape seed and pine bark extracts. , 2007, Journal of agricultural and food chemistry.
[33] P. Codogno,et al. AMP-Activated Protein Kinase and Autophagy , 2007, Autophagy.
[34] Deepak Kanojia,et al. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. , 2006, Oral oncology.
[35] A. Dennison,et al. Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic Consequences , 2006, Clinical Cancer Research.
[36] I. Angelillo,et al. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. , 2006, The American journal of clinical nutrition.
[37] L. Thompson,et al. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours , 2006, Ear, nose, & throat journal.
[38] Jacinto J. Regalado,et al. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma , 2005, International journal of experimental pathology.
[39] E. Sausville,et al. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. , 2005, Cancer research.
[40] B. Aggarwal,et al. Role of chemopreventive agents in cancer therapy. , 2004, Cancer letters.
[41] N. Seeram,et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.
[42] S. Tickoo,et al. Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice , 2004, Clinical Cancer Research.
[43] M. Kikuchi,et al. Procyanidin B1 Is Detected in Human Serum after Intake of Proanthocyanidin-rich Grape Seed Extract , 2003, Bioscience, biotechnology, and biochemistry.
[44] Takuji Tanaka,et al. Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. , 2002, Carcinogenesis.
[45] M. Kikuchi,et al. Safety evaluation of proanthocyanidin-rich extract from grape seeds. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[46] D. Bagchi,et al. Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract. , 2001, Research communications in molecular pathology and pharmacology.
[47] A. Hara,et al. Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis , 1999, International journal of cancer.
[48] P. Boyle,et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. , 1995, European journal of cancer. Part B, Oral oncology.
[49] J. M. Nauta,et al. Comparison of epithelial dysplasia--the 4NQO rat palate model and human oral mucosa. , 1995, International journal of oral and maxillofacial surgery.
[50] A. Nishikawa,et al. Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats. , 1989, Cancer letters.
[51] P. Auberger,et al. When autophagy meets cancer through p62/SQSTM1. , 2012, American journal of cancer research.
[52] G. Rajesh,et al. Retrospective study on risk habits among oral cancer patients in Karnataka Cancer Therapy and Research Institute, Hubli, India. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[53] A. Mueller,et al. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database , 2009, Journal of Cancer Research and Clinical Oncology.
[54] A. Gruzman,et al. Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations. , 2009, The review of diabetic studies : RDS.
[55] D. Brachman,et al. Molecular biology of head and neck cancer. , 1994, Seminars in oncology.
[56] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.